Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer.

J Pers Med · 2021 · PMC8145096 · PMID 33923231

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The treatment of xenografts with 200 nM Talazoparib resulted in a highly significant reduction of tumor growth (80%) five days after treatment ( Figure 3 D).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.